Bessemer Group’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Bessemer Group's TRAX Position: Q3 2026 in Review
Bessemer Group held its First Tracks Biotherapeutics (TRAX) position steady in Q3 2026 at 1,428 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #1725.
Bessemer Group first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Bessemer Group held 1,428 shares of First Tracks Biotherapeutics worth $50K as of Q3 2026.
- Bessemer Group left its First Tracks Biotherapeutics share count unchanged in Q3 2026.
- First Tracks Biotherapeutics made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #1725 holding.
- Bessemer Group first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.